Media headlines about Bunge (NYSE:BG) have trended somewhat positive this week, Accern reports. Accern rates the sentiment of news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Bunge earned a news impact score of 0.12 on Accern’s scale. Accern also assigned news articles about the basic materials company an impact score of 45.72391271427 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Here are some of the news articles that may have effected Accern’s rankings:
Bunge (NYSE BG) opened at $79.43 on Thursday. The company has a market cap of $11,241.67, a PE ratio of 24.90, a PEG ratio of 1.48 and a beta of 1.05. The company has a current ratio of 1.60, a quick ratio of 0.82 and a debt-to-equity ratio of 0.60. Bunge has a 52-week low of $63.87 and a 52-week high of $83.75.
Bunge (NYSE:BG) last posted its quarterly earnings results on Wednesday, November 1st. The basic materials company reported $0.75 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.79 by ($0.04). Bunge had a return on equity of 6.68% and a net margin of 1.06%. The business had revenue of $11.42 billion during the quarter, compared to analyst estimates of $11.87 billion. During the same period last year, the company earned $0.73 EPS. The business’s revenue for the quarter was up .0% on a year-over-year basis. sell-side analysts forecast that Bunge will post 2.97 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, March 2nd. Investors of record on Friday, February 16th will be given a $0.46 dividend. This represents a $1.84 annualized dividend and a yield of 2.32%. The ex-dividend date is Thursday, February 15th. Bunge’s dividend payout ratio (DPR) is presently 57.68%.
Several brokerages have issued reports on BG. Zacks Investment Research raised shares of Bunge from a “strong sell” rating to a “hold” rating in a research note on Tuesday. BMO Capital Markets reissued a “buy” rating and set a $87.00 target price on shares of Bunge in a research note on Monday, November 6th. Vertical Group upgraded shares of Bunge from a “hold” rating to a “buy” rating in a report on Thursday, December 14th. Credit Suisse Group set a $84.00 price target on shares of Bunge and gave the company a “buy” rating in a report on Monday, January 22nd. Finally, Piper Jaffray Companies set a $86.00 price objective on shares of Bunge and gave the stock a “buy” rating in a report on Friday, October 6th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and four have assigned a buy rating to the company. Bunge presently has a consensus rating of “Hold” and an average price target of $81.00.
TRADEMARK VIOLATION NOTICE: This article was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this article on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2018/02/01/bunge-bg-earns-daily-news-sentiment-rating-of-0-12.html.
Bunge Company Profile
Bunge Limited is an agribusiness and food company with integrated operations that stretch from the farm field to consumer foods. The Company operates through five segments: Agribusiness, Edible Oil Products, Milling Products, Sugar and Bioenergy, and Fertilizer. Its Agribusiness segment is an integrated, global business involved in the purchase, storage, transport, processing and sale of agricultural commodities and commodity products.
Receive News & Ratings for Bunge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bunge and related companies with MarketBeat.com's FREE daily email newsletter.